Authors
Pietro Ravani, Alberto Magnasco, Alberto Edefonti, Luisa Murer, Rossella Rossi, Luciana Ghio, Elisa Benetti, Floriana Scozzola, Andrea Pasini, Nadia Dallera, Felice Sica, Mirco Belingheri, Francesco Scolari, Gian Marco Ghiggeri
Publication date
2011/6/1
Journal
Clinical Journal of the American Society of Nephrology
Volume
6
Issue
6
Pages
1308-1315
Publisher
LWW
Description
Results
Fifty-four children (mean age 11±4 years) with INS dependent on prednisone and calcineurin inhibitors for> 12 months were randomized. Three-month proteinuria was 70% lower in the RTX arm (95% confidence interval 35% to 86%) as compared with standard therapy arm (intention-to-treat); relapse rates were 18.5%(intervention) and 48.1%(standard arm)(P= 0.029). Probabilities of being drug-free at 3 months were 62.9% and 3.7%, respectively (P< 0.001); 50% of RTX cases were in stable remission without drugs after 9 months.
Conclusions
Rituximab and lower doses of prednisone and calcineurin inhibitors are noninferior to standard therapy in maintaining short-term remission in children with INS dependent on both drugs and allow their temporary withdrawal.
Total citations
2010201120122013201420152016201720182019202020212022202320241310232326202017151415152111
Scholar articles
P Ravani, A Magnasco, A Edefonti, L Murer, R Rossi… - Clinical Journal of the American Society of Nephrology, 2011